Parnell Pharma Revenue, Profits - PARNF Quarterly Income Statement

Add to My Stocks
$0.2 $0.05 (20%) PARNF stock closing price Jun 19, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Parnell Pharma stock price alone is not sufficient. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the PARNF stock is bound to reflect the impact of the QOQ decline of -6.18%. One also needs to look at Parnell Pharma assets, operating expenses and Parnell Pharma free cash flow. The Parnell Pharma profit and loss statement shows revenue of $3.95M for 2016 Q4. Revenue has decreased by -6.18% QoQ for PARNF stock.

View and download details of revenue and profits for Parnell Pharma for latest & last 40 quarters.
show more
Fiscal year is Jan - Dec2016 Q42016 Q32015 Q4
Parnell Pharma Revenues or Net Sales
3.95M4.21M3.37M
Cost Of Goods Sold (COGS)---
Parnell Pharma Gross Profit
---
Research & Development Expense---
Selling General & Admin Expense---
Income Before Depreciation Depletion Amortization---
Depreciation Depletion Amortization---
Non Operating Income---
Interest Expense---
Parnell Pharma Pretax Income
---
Provision for Income Taxes---
MinorityInterest---
Investment Gains Losses---
Other Income---
Income Before Extraordinaries & Disc Operations-2.33M-4.63M-5.99M
Extraordinary Items & Discontinued Operations---
Parnell Pharma Profit/ Loss (Net Income)
-2.33M-4.63M-5.99M
Average Shares used to compute Diluted EPS19.42M15.36M13.42M
Average Shares used to compute Basic EPS19.42M15.36M13.42M
Income Before Nonrecurring Items-2.33M-4.63M-5.99M
Income from Nonrecurring Items---
Parnell Pharma Earnings Per Share Basic Net
-0.12-0.27-0.45
Parnell Pharma Earnings Per Share Diluted Net
-0.12-0.27-0.45
EPS Diluted Before Nonrecurring Items-0.12-0.27-0.45
Preferred Dividends Acc Pd---
Dividends Common---
Dividend Per Share Common0.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Parnell Pharma stock analysis. It helps to look at the following income statement items:

  • Topline: A growing topline, as seen from the Parnell Pharma revenue chart, as isn't the case with Parnell Pharma indicates a sagging business. One needs to compare the QoQ topline or sales growth of PARNF stock with its peers like SUWN stock and ACUR stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-2.33M for PARNF stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the PARNF income statement, one can check the Parnell Pharma historical stock prices to check how the price has moved with time.

Parnell Pharma Income Statement - Key Financial Ratios

Other Income Statements - Parnell Pharmaceuticals Holdings Ltd Industry Peers

Amerisourcebergen income statement, Acura Pharma income statement, GlobeImmune income statement, Sunwin Stevia income statement